CoChat
Sign Up
Cited by 20

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Genome-wide association study of hippocampal atrophy rate in non-demented elders

Guo, Yu, on behalf of Alzheimer’s Disease Neuroimaging Initiative, Xu, Wei, Li, Jie-Qiong, Ou, Ya-Nan, Shen, Xue-Ning, Huang, Yu-Yuan, Dong, Qiang, Tan, Lan, Yu, Jin-Tai·2019·Aging
DOI 10.18632/aging.102470
Open this paper in CoChat — free account

Verifying this paper

8 of 9 steps done · this page updates itself — you can leave and come back

  1. Registry recordVerified
  2. Full textFetching the open-access text — a few minutes for a paper we haven’t read before
  3. Reference listNot fetched yet
  4. Reference checkNot run yet for this paper
  5. StatisticsNeeds the full text
  6. ClaimsNeeds the full text
  7. Cited sourcesNeeds claims to check
  8. Self-checkNeeds the full text
  9. VerificationFindings verified

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/aging.102470

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In TOMM40-APOC1, SNPs including rs4420638, rs56131196, and rs157582 have been identified as significant loci associated with hippocampal volume atrophy and accelerated cognitive decline in patients with MCI.

    “In the TOMM40-APOC1, single-nucleotide polymorphisms (SNPs), including rs4420638, rs56131196, and rs157582, have been identified as significant loci associated with hippocampal volume (HV) atrophy and accelerated cognitive decline in patients with mild cognitive impairment (MCI) [24].”

    From Association of APOC1 with cortical atrophy during conversion to Alzheimer’s disease (2025) · cites this paper as [24]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 43

  1. Knierim, 2015, The hippocampus., Curr Biol, 2, R1116, 10.1016/j.cub.2015.10.049 · DOI
  2. McEwen, 1997, Possible mechanisms for atrophy of the human hippocampus., Mol Psychiatry, 2, 255, 10.1038/sj.mp.4000254 · DOI · Paper page
  3. Breteler, 2010, A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline., Brain, 13, 1163, 10.1093/brain/awq048 · DOI · Paper page
  4. Fox, 2009, A meta-analysis of hippocampal atrophy rates in Alzheimer’s disease., Neurobiol Aging, 3, 1711, 10.1016/j.neurobiolaging.2008.01.010 · DOI · Paper page
  5. Joly, 2013, Evaluating Alzheimer’s disease progression using rate of regional hippocampal atrophy., PLoS One, 8, e71354, 10.1371/journal.pone.0071354 · DOI
  6. Barkhof, 2009, Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures., Neurology, 7, 999, 10.1212/01.wnl.0000344568.09360.31 · DOI · Paper page
  7. Josephs, 2011, Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN., Neurology, 7, 393, 10.1212/WNL.0b013e318227047f · DOI
  8. Chui, 2005, Longitudinal volumetric MRI change and rate of cognitive decline., Neurology, 6, 565, 10.1212/01.wnl.0000172913.88973.0d · DOI · Paper page
  9. and, 2016, Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis., Neurobiol Aging, 3, 99, 10.1016/j.neurobiolaging.2015.10.013 · DOI
  10. van der Flier, 2009, Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease., Neurology, 7, 935, 10.1212/WNL.0b013e3181b879ac · DOI
  11. Kokmen, 1998, Rate of medial temporal lobe atrophy in typical aging and Alzheimer’s disease., Neurology, 5, 993, 10.1212/WNL.51.4.993 · DOI · Paper page
  12. Saykin, 2012, Pathway analysis of genomic data: concepts, methods, and prospects for future development., Trends Genet, 2, 323, 10.1016/j.tig.2012.03.004 · DOI
  13. Burn, 2013, Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson’s disease?, Mov Disord, 2, 425, 10.1002/mds.25352 · DOI
  14. Hughes, 2018, Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci., Sci Rep, 8, 18088, 10.1038/s41598-018-36429-6 · DOI
  15. Jones, 2013, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease., Nat Genet, 4, 1452, 10.1038/ng.2802 · DOI · Paper page
  16. Veldink, 2013, Systematic identification of trans eQTLs as putative drivers of known disease associations., Nat Genet, 4, 1238, 10.1038/ng.2756 · DOI · Paper page
  17. Pattie, 2014, A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing., Mol Psychiatry, 1, 76, 10.1038/mp.2012.159 · DOI
  18. Reiman, 2010, A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer’s disease., Pharmacogenomics J, 1, 375, 10.1038/tpj.2009.69 · DOI
  19. Dokken, 2005, Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology., Nucleic Acids Res, 3, e149, 10.1093/nar/gni155 · DOI
  20. Deary, 2012, APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921., Mol Psychiatry, 1, 315, 10.1038/mp.2010.137 · DOI
  21. Ji, 2016, Shared Genetic Etiology between Type 2 Diabetes and Alzheimer’s Disease Identified by Bioinformatics Analysis., J Alzheimers Dis, 5, 13
  22. Prescott, 2017, Genetic variants specific to aging-related verbal memory: insights from GWASs in a population-based cohort., PLoS One, 1, e0182448, 10.1371/journal.pone.0182448 · DOI
  23. Moral, 2001, MRI and genetic correlates of cognitive function in elders with memory impairment., Neurobiol Aging, 2, 449, 10.1016/S0197-4580(01)00207-X · DOI
  24. Moral, 2001, APOE and APOC1 genetic polymorphisms in age-associated memory impairment., Neurogenetics, 3, 215, 10.1007/s100480100122 · DOI
  25. Poirier, 2010, APOE and cholesterol homeostasis in Alzheimer’s disease., Trends Mol Med, 1, 469, 10.1016/j.molmed.2010.07.008 · DOI
  26. Elston, 1998, Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer’s disease., Neurology, 5, 131, 10.1212/WNL.51.1.131 · DOI
  27. Shelly, 1998, The apolipoprotein CI A allele as a risk factor for Alzheimer’s disease., Neurochem Res, 2, 361, 10.1023/A:1022409617539 · DOI
  28. Johnson, 2017, Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer’s disease cohorts., Alzheimers Dement, 1, 1217, 10.1016/j.jalz.2017.03.009 · DOI
  29. Bookheimer, 2017, Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant., Alzheimers Dement, 1, 739, 10.1016/j.jalz.2016.12.009 · DOI
  30. Roses, 2010, Genetic variation at a single locus and age of onset for Alzheimer’s disease., Alzheimers Dement, 6, 125, 10.1016/j.jalz.2010.01.011 · DOI
  31. Yu, 2012, Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE., J Hum Genet, 5, 18, 10.1038/jhg.2011.123 · DOI
  32. Smith, 2018, DNA methylation in the APOE genomic region is associated with cognitive function in African Americans., BMC Med Genomics, 1, 43, 10.1186/s12920-018-0363-9 · DOI
  33. Asada, 2012, Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype., Am J Geriatr Psychiatry, 2, 574, 10.1097/JGP.0b013e318211819b · DOI
  34. Amouyel, 2005, Is there a relation between APOE expression and brain amyloid load in Alzheimer’s disease?, J Neurol Neurosurg Psychiatry, 7, 928, 10.1136/jnnp.2004.048983 · DOI
  35. Krishnan, 2012, Downregulation of TOMM40 expression in the blood of Alzheimer disease subjects compared with matched controls., J Psychiatr Res, 4, 828, 10.1016/j.jpsychires.2012.03.006 · DOI
  36. Nilsen, 2007, Mechanisms of microRNA-mediated gene regulation in animal cells., Trends Genet, 2, 243, 10.1016/j.tig.2007.02.011 · DOI
  37. Ro, 2014, MicroRNA signature for HER2-positive breast and gastric cancer., Anticancer Res, 3, 3807
  38. Huang, 2009, MicroRNA profiling of human gastric cancer., Mol Med Rep, 2, 963, 10.3892/mmr_00000199 · DOI
  39. Wang, 2018, Circulating miRNA-302 family members as potential biomarkers for the diagnosis of acute heart failure., Biomark Med, 1, 871, 10.2217/bmm-2018-0132 · DOI
  40. Lee, 2015, Second-generation PLINK: rising to the challenge of larger and richer datasets., Gigascience, 4, 7, 10.1186/s13742-015-0047-8 · DOI · Paper page
  41. Frisoni, 2013, Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease., Neurology, 8, 1048, 10.1212/WNL.0b013e3182872830 · DOI · Paper page
  42. Dale, 2002, Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain., Neuron, 3, 341, 10.1016/S0896-6273(02)00569-X · DOI · Paper page
  43. Merikangas, 1996, The future of genetic studies of complex human diseases., Science, 27, 1516, 10.1126/science.273.5281.1516 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Guo, Y., Initiative, O. B. O. A. D. N., Xu, W., Li, J.-Q., Ou, Y.-N., Shen, X.-N., Huang, Y.-Y., Dong, Q., Tan, L., & Yu, J.-T.
Affiliations
  • Department of Neurology, Qingdao Municipal Hospital Affiliated to Qingdao University, Qingdao, China
  • Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
Venue
Aging
Publisher
Impact Journals, LLC
Published
2019-11-23
Volume
11
Issue
22
Pages
10468-10484
ISSN
1945-4589
DOI
10.18632/aging.102470
Cited by
20
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review